Annual Net Income
-$179.05 M
-$13.30 M-8.02%
31 December 2023
Summary:
BioXcel Therapeutics annual net profit is currently -$179.05 million, with the most recent change of -$13.30 million (-8.02%) on 31 December 2023. During the last 3 years, it has fallen by -$96.88 million (-117.91%). BTAI annual net income is now -8345.90% below its all-time high of -$2.12 million, reached on 31 December 2016.BTAI Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Net Income
-$13.65 M
-$5.35 M-64.48%
30 September 2024
Summary:
BioXcel Therapeutics quarterly net profit is currently -$13.65 million, with the most recent change of -$5.35 million (-64.48%) on 30 September 2024. Over the past year, it has increased by +$36.84 million (+72.96%). BTAI quarterly net income is now -2480.34% below its all-time high of -$529.00 thousand, reached on 31 March 2017.BTAI Quarterly Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM Net Income
-$71.00 M
+$36.84 M+34.16%
30 September 2024
Summary:
BioXcel Therapeutics TTM net profit is currently -$71.00 million, with the most recent change of +$36.84 million (+34.16%) on 30 September 2024. Over the past year, it has increased by +$140.61 million (+66.45%). BTAI TTM net income is now -13320.79% below its all-time high of -$529.00 thousand, reached on 31 March 2017.BTAI TTM Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
BTAI Net Income Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -8.0% | +73.0% | +66.5% |
| 3 y3 years | -117.9% | +49.1% | +30.3% |
| 5 y5 years | -829.2% | -51.4% | -123.5% |
BTAI Net Income High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -117.9% | at low | -64.5% | +75.1% | at high | +66.5% |
| 5 y | 5 years | -829.2% | at low | -65.0% | +75.1% | -123.5% | +66.5% |
| alltime | all time | -8345.9% | at low | -2480.3% | +75.1% | <-9999.0% | +66.5% |
BioXcel Therapeutics Net Income History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$13.65 M(+64.5%) | -$71.00 M(-34.2%) |
| June 2024 | - | -$8.30 M(-69.0%) | -$107.83 M(-29.5%) |
| Mar 2024 | - | -$26.79 M(+20.4%) | -$153.05 M(-14.5%) |
| Dec 2023 | -$179.05 M(+8.0%) | -$22.26 M(-55.9%) | -$179.05 M(-15.4%) |
| Sept 2023 | - | -$50.49 M(-5.7%) | -$211.60 M(+4.3%) |
| June 2023 | - | -$53.52 M(+1.4%) | -$202.92 M(+8.5%) |
| Mar 2023 | - | -$52.80 M(-3.7%) | -$187.08 M(+12.9%) |
| Dec 2022 | -$165.76 M(+55.0%) | -$54.81 M(+31.1%) | -$165.75 M(+20.9%) |
| Sept 2022 | - | -$41.80 M(+11.0%) | -$137.07 M(+12.3%) |
| June 2022 | - | -$37.67 M(+19.7%) | -$122.08 M(+9.0%) |
| Mar 2022 | - | -$31.47 M(+20.5%) | -$112.03 M(+4.8%) |
| Dec 2021 | -$106.93 M(+30.1%) | -$26.13 M(-2.6%) | -$106.93 M(+4.9%) |
| Sept 2021 | - | -$26.81 M(-2.9%) | -$101.89 M(+2.1%) |
| June 2021 | - | -$27.62 M(+4.7%) | -$99.83 M(+6.6%) |
| Mar 2021 | - | -$26.38 M(+25.1%) | -$93.63 M(+14.0%) |
| Dec 2020 | -$82.17 M | -$21.09 M(-14.8%) | -$82.17 M(+18.5%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2020 | - | -$24.75 M(+15.6%) | -$69.36 M(+29.3%) |
| June 2020 | - | -$21.42 M(+43.6%) | -$53.62 M(+31.8%) |
| Mar 2020 | - | -$14.91 M(+80.2%) | -$40.67 M(+23.4%) |
| Dec 2019 | -$32.97 M(+71.1%) | -$8.28 M(-8.2%) | -$32.97 M(+3.8%) |
| Sept 2019 | - | -$9.02 M(+6.5%) | -$31.77 M(+14.9%) |
| June 2019 | - | -$8.47 M(+17.6%) | -$27.64 M(+24.5%) |
| Mar 2019 | - | -$7.20 M(+1.8%) | -$22.19 M(+15.2%) |
| Dec 2018 | -$19.27 M(+324.5%) | -$7.08 M(+44.8%) | -$19.27 M(+30.9%) |
| Sept 2018 | - | -$4.89 M(+61.5%) | -$14.72 M(+36.9%) |
| June 2018 | - | -$3.03 M(-29.3%) | -$10.75 M(+29.7%) |
| Mar 2018 | - | -$4.28 M(+69.4%) | -$8.29 M(+82.7%) |
| Dec 2017 | -$4.54 M(+114.1%) | -$2.53 M(+175.7%) | -$4.54 M(+125.7%) |
| Sept 2017 | - | -$917.00 K(+62.3%) | -$2.01 M(+83.8%) |
| June 2017 | - | -$565.00 K(+6.8%) | -$1.09 M(+106.8%) |
| Mar 2017 | - | -$529.00 K | -$529.00 K |
| Dec 2016 | -$2.12 M | - | - |
FAQ
- What is BioXcel Therapeutics annual net profit?
- What is the all time high annual net income for BioXcel Therapeutics?
- What is BioXcel Therapeutics annual net income year-on-year change?
- What is BioXcel Therapeutics quarterly net profit?
- What is the all time high quarterly net income for BioXcel Therapeutics?
- What is BioXcel Therapeutics quarterly net income year-on-year change?
- What is BioXcel Therapeutics TTM net profit?
- What is the all time high TTM net income for BioXcel Therapeutics?
- What is BioXcel Therapeutics TTM net income year-on-year change?
What is BioXcel Therapeutics annual net profit?
The current annual net income of BTAI is -$179.05 M
What is the all time high annual net income for BioXcel Therapeutics?
BioXcel Therapeutics all-time high annual net profit is -$2.12 M
What is BioXcel Therapeutics annual net income year-on-year change?
Over the past year, BTAI annual net profit has changed by -$13.30 M (-8.02%)
What is BioXcel Therapeutics quarterly net profit?
The current quarterly net income of BTAI is -$13.65 M
What is the all time high quarterly net income for BioXcel Therapeutics?
BioXcel Therapeutics all-time high quarterly net profit is -$529.00 K
What is BioXcel Therapeutics quarterly net income year-on-year change?
Over the past year, BTAI quarterly net profit has changed by +$36.84 M (+72.96%)
What is BioXcel Therapeutics TTM net profit?
The current TTM net income of BTAI is -$71.00 M
What is the all time high TTM net income for BioXcel Therapeutics?
BioXcel Therapeutics all-time high TTM net profit is -$529.00 K
What is BioXcel Therapeutics TTM net income year-on-year change?
Over the past year, BTAI TTM net profit has changed by +$140.61 M (+66.45%)